204 related articles for article (PubMed ID: 32509183)
1. Expression levels of lncRNAs are prognostic for hepatocellular carcinoma overall survival.
Xue C; Zhao Y; Jiang J; Li L
Am J Transl Res; 2020; 12(5):1873-1883. PubMed ID: 32509183
[TBL] [Abstract][Full Text] [Related]
2. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
[TBL] [Abstract][Full Text] [Related]
3. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
Zhao QJ; Zhang J; Xu L; Liu FF
World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
[TBL] [Abstract][Full Text] [Related]
4. Identification and Validation of a Prognostic lncRNA Signature for Hepatocellular Carcinoma.
Li W; Chen QF; Huang T; Wu P; Shen L; Huang ZL
Front Oncol; 2020; 10():780. PubMed ID: 32587825
[No Abstract] [Full Text] [Related]
5. A three-mRNA status risk score has greater predictive ability compared with a lncRNA-based risk score for predicting prognosis in patients with hepatocellular carcinoma.
Zhang W; Fu Q; Yao K
Oncol Lett; 2020 Oct; 20(4):48. PubMed ID: 32788937
[TBL] [Abstract][Full Text] [Related]
6. Genome-Wide Analysis of Prognostic lncRNAs, miRNAs, and mRNAs Forming a Competing Endogenous RNA Network in Hepatocellular Carcinoma.
Lin P; Wen DY; Li Q; He Y; Yang H; Chen G
Cell Physiol Biochem; 2018; 48(5):1953-1967. PubMed ID: 30092571
[TBL] [Abstract][Full Text] [Related]
7. Eight key long non-coding RNAs predict hepatitis virus positive hepatocellular carcinoma as prognostic targets.
Huang ZL; Li W; Chen QF; Wu PH; Shen LJ
World J Gastrointest Oncol; 2019 Nov; 11(11):983-997. PubMed ID: 31798779
[TBL] [Abstract][Full Text] [Related]
8. Characterization of long non-coding RNAs to reveal potential prognostic biomarkers in hepatocellular carcinoma.
Ma Y; Luo T; Dong D; Wu X; Wang Y
Gene; 2018 Jul; 663():148-156. PubMed ID: 29684484
[TBL] [Abstract][Full Text] [Related]
9. Identification of four prognostic LncRNAs for survival prediction of patients with hepatocellular carcinoma.
Wang Z; Wu Q; Feng S; Zhao Y; Tao C
PeerJ; 2017; 5():e3575. PubMed ID: 28729955
[TBL] [Abstract][Full Text] [Related]
10. Identification of long noncoding RNAs biomarkers in patients with hepatitis B virus-associated hepatocellular carcinoma.
Mou Y; Wang D; Xing R; Nie H; Mou Y; Zhang Y; Zhou X
Cancer Biomark; 2018; 23(1):95-106. PubMed ID: 29991128
[TBL] [Abstract][Full Text] [Related]
11. Construction of a long non-coding RNA-associated ceRNA network reveals potential prognostic lncRNA biomarkers in hepatocellular carcinoma.
Yan Y; Yu J; Liu H; Guo S; Zhang Y; Ye Y; Xu L; Ming L
Pathol Res Pract; 2018 Dec; 214(12):2031-2038. PubMed ID: 30316688
[TBL] [Abstract][Full Text] [Related]
12. Systematic analyses of a novel lncRNA-associated signature as the prognostic biomarker for Hepatocellular Carcinoma.
Sui J; Miao Y; Han J; Nan H; Shen B; Zhang X; Zhang Y; Wu Y; Wu W; Liu T; Xu S; Yang S; Yin L; Pu Y; Liang G
Cancer Med; 2018 Jul; 7(7):3240-3256. PubMed ID: 29761859
[TBL] [Abstract][Full Text] [Related]
13. A Co-Expression Network Reveals the Potential Regulatory Mechanism of lncRNAs in Relapsed Hepatocellular Carcinoma.
Fang Y; Yang Y; Zhang X; Li N; Yuan B; Jin L; Bao S; Li M; Zhao D; Li L; Zeng Z; Huang H
Front Oncol; 2021; 11():745166. PubMed ID: 34532296
[TBL] [Abstract][Full Text] [Related]
14. A five lncRNA signature for prognosis prediction in hepatocellular carcinoma.
Sun Y; Zhang F; Wang L; Song X; Jing J; Zhang F; Yu S; Liu H
Mol Med Rep; 2019 Jun; 19(6):5237-5250. PubMed ID: 31059056
[TBL] [Abstract][Full Text] [Related]
15. Characterization of Hepatocellular Carcinoma Cell Lines Using a Fractionation-Then-Sequencing Approach Reveals Nuclear-Enriched HCC-Associated lncRNAs.
Chow EY; Zhang J; Qin H; Chan TF
Front Genet; 2019; 10():1081. PubMed ID: 31781161
[No Abstract] [Full Text] [Related]
16. Identification of Two Molecular Subtypes of Hepatocellular Carcinoma Based on Dysregulated Immune LncRNAs.
Lin H; Xie Y; Kong Y; Yang L; Li M
Front Mol Biosci; 2021; 8():625858. PubMed ID: 34888348
[TBL] [Abstract][Full Text] [Related]
17. Identification and validation of potential prognostic lncRNA biomarkers for predicting survival in patients with multiple myeloma.
Zhou M; Zhao H; Wang Z; Cheng L; Yang L; Shi H; Yang H; Sun J
J Exp Clin Cancer Res; 2015 Sep; 34(1):102. PubMed ID: 26362431
[TBL] [Abstract][Full Text] [Related]
18. A novel seven-lncRNA signature for prognosis prediction in hepatocellular carcinoma.
Yan J; Zhou C; Guo K; Li Q; Wang Z
J Cell Biochem; 2019 Jan; 120(1):213-223. PubMed ID: 30206981
[TBL] [Abstract][Full Text] [Related]
19. Integrated analysis of a competing endogenous RNA network reveals key long noncoding RNAs as potential prognostic biomarkers for hepatocellular carcinoma.
Ye J; Zhang J; Lv Y; Wei J; Shen X; Huang J; Wu S; Luo X
J Cell Biochem; 2019 Aug; 120(8):13810-13825. PubMed ID: 30989713
[TBL] [Abstract][Full Text] [Related]
20. Investigation of long noncoding RNAs expression profile as potential serum biomarkers in patients with hepatocellular carcinoma.
Kamel MM; Matboli M; Sallam M; Montasser IF; Saad AS; El-Tawdi AHF
Transl Res; 2016 Feb; 168():134-145. PubMed ID: 26551349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
